Haploidentical donor transplant is associated with secondary poor graft function after allogeneic stem cell transplantation: A single‐center retrospective study

Donor-Specific Anti-HLA Antibodies in Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide: Risk of Graft Failure, Poor Graft Function, and Impact on Outcomes

(2019) Stefania Bramanti et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Virus reactivation and low dose of CD34+ cell, rather than haploidentical transplantation, were associated with secondary poor graft function within the first 100 days after allogeneic stem cell transplantation

(2019) Yu-Qian Sun et al.   ANNALS OF HEMATOLOGY

Haploidentical allogeneic hematopoietic stem cell transplantation increases the risk of cytomegalovirus infection in adult patients with acute leukemia

(2019) Cheng‐Hsien Lin et al.   Transplant Infectious Disease

Autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation in adults: A southern China multicenter experience

(2019) Weiran Lv et al.   Cancer Medicine

Haploidentical Transplantation Without In Vitro T-Cell Depletion Results in Outcomes Equivalent to Those of Contemporaneous Matched Sibling and Unrelated Donor Transplantation for Acute Leukemia

(2016) Sijian Yu et al.   MEDICINE

Eltrombopag after allogeneic haematopoietic cell transplantation in a case of poor graft function and systematic review of the literature

(2016) J. Dyba et al.   TRANSFUSION MEDICINE

Sequential intensified conditioning followed by prophylactic DLI could reduce relapse of refractory acute leukemia after allo-HSCT

(2016) Li Xuan et al.   Oncotarget

The incidence, risk factors, and outcomes of primary poor graft function after unmanipulated haploidentical stem cell transplantation

(2015) Yu-Qian Sun et al.   ANNALS OF HEMATOLOGY

Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study

(2015) Yu Wang et al.   BLOOD

Low-Dose Decitabine for Patients With Thrombocytopenia Following Allogeneic Hematopoietic Stem Cell Transplantation

(2015) Yue Han et al.   JAMA Oncology

Graft-versus-Host Disease Causes Broad Suppression of Hematopoietic Primitive Cells and Blocks Megakaryocyte Differentiation in a Murine Model

(2014) Yan Lin et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Risk-Factor Analysis of Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation

(2014) Yang Xiao et al.   International Journal of Medical Sciences

Concise Review: The Bone Marrow Niche as a Target of Graft Versus Host Disease

(2014) Malte von Bonin et al.   STEM CELLS

Improvement in Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation upon Administration of Mesenchymal Stem Cells from Third-Party Donors: A Pilot Prospective Study

(2013) Xiaodan Liu et al.   CELL TRANSPLANTATION

Effects of intensified conditioning on Epstein-Barr virus and cytomegalovirus infections in allogeneic hematopoietic stem cell transplantation for hematological malignancies

(2012) Li Xuan et al.   Journal of Hematology & Oncology

Donor-specific anti-HLA Abs and graft failure in matched unrelated donor hematopoietic stem cell transplantation

(2011) S. O. Ciurea et al.   BLOOD

Cytopenias after day 28 in allogeneic hematopoietic cell transplantation: impact of recipient/donor factors, transplant conditions and myelotoxic drugs

(2011) H. Nakamae et al.   HAEMATOLOGICA

Cotransplantation of Mesenchymal Stem Cells Might Prevent Death from Graft-versus-Host Disease (GVHD) without Abrogating Graft-versus-Tumor Effects after HLA-Mismatched Allogeneic Transplantation following Nonmyeloablative Conditioning

(2010) Frédéric Baron et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Platelet Engraftment in Patients with Hematologic Malignancies following Unmanipulated Haploidentical Blood and Marrow Transplantation: Effects of CD34+ Cell Dose and Disease Status

(2009) Ying-Jun Chang et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION